Treatment Satisfaction With Ra-223 in Japan
NCT03315260
·
clinicaltrials.gov ↗
COMPLETED
Status
85
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Neoplasms
Interventions
DRUG:
Radium-223 dichloride (Xofigo, BAY88-8223)
Sponsor
Bayer